Literature DB >> 16525640

Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells.

Danilo Millimaggi1, Claudio Festuccia, Adriano Angelucci, Sandra D'Ascenzo, Nadia Rucci, Silvio Flati, Mauro Bologna, Anna Teti, Antonio Pavan, Vincenza Dolo.   

Abstract

Although it has been shown that the cross-talk between osteoblasts and tumor cells stimulates proliferation and invasion of prostate carcinoma (PCa) cells, the molecular mechanisms underlying this event are largely unknown. In this study, we demonstrated that the PCa cells, PC3, derived from bone metastasis, undergo changes of their invasive capability if grown in the presence of osteoblast-derived conditioned media (OBCM). Specifically, they were able to organize tridimensional structures in Matrigel, such as large branching colonies, tube-like structures and clusters of proliferating cells, after treatment. At the ultrastructural level, we observed that PC3 cells grown in the presence of OBCM presented an increment of membrane activity with a blast of shed membrane vesicles from the cell surface. After 6 h of incubation, protein content was approximately 5-fold more elevated in vesicles isolated from PC3 cells cultured in OBCM than in unstimulated cultures. Gelatin zymography of vesicles collected from OBCM-treated PC3 cells showed an increment of lytic bands of MMP family members identified as pro-enzymatic and active forms of gelatinase A (MMP-2) and gelatinase B (MMP-9). By casein-plasminogen zymography, this latter culture also presented an elevated level of high-molecular weight urokinase plasminogen activator (HMW-uPA). Purified vesicles from OBCM-treated PC3 cells incubated with Matrigel cleaved its components more efficiently than vesicles from untreated PC3 cells. Collectively, these findings indicate that osteoblasts produce factor/s able to modify the invasive capability of prostate cancer cells, increasing the amount of shed vesicles and of their associated lytic enzymes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525640

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts.

Authors:  Shuming Zhang; Jun Wang; Mehmet A Bilen; Sue-Hwa Lin; Samuel I Stupp; Robert L Satcher
Journal:  Clin Exp Metastasis       Date:  2009-09-29       Impact factor: 5.150

2.  Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.

Authors:  Leyre Brizuela; Claire Martin; Pauline Jeannot; Isabelle Ader; Cécile Gstalder; Guillaume Andrieu; Magalie Bocquet; Jean-Michel Laffosse; Anne Gomez-Brouchet; Bernard Malavaud; Roger A Sabbadini; Olivier Cuvillier
Journal:  Mol Oncol       Date:  2014-04-13       Impact factor: 6.603

Review 3.  Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

Authors:  Kalyani C Patil; Carolina Soekmadji
Journal:  Subcell Biochem       Date:  2021

4.  Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells.

Authors:  Danilo Millimaggi; Marianna Mari; Sandra D'Ascenzo; Eleonora Carosa; Emmanuele Angelo Jannini; Stanley Zucker; Gaspare Carta; Antonio Pavan; Vincenza Dolo
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

Review 5.  A Molecular View of Pathological Microcalcification in Breast Cancer.

Authors:  Tanu Sharma; James A Radosevich; Geeta Pachori; Chandi C Mandal
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-01-15       Impact factor: 2.673

6.  Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation.

Authors:  Tomohiro Itoh; Yuko Ito; Yoshinori Ohtsuki; Masashi Ando; Yasuyuki Tsukamasa; Nami Yamada; Tomoki Naoe; Yukihiro Akao
Journal:  J Mol Histol       Date:  2012-04-17       Impact factor: 2.611

7.  X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser.

Authors:  Elizabeth M Bolitho; Carlos Sanchez-Cano; Huaiyi Huang; Ian Hands-Portman; Matthew Spink; Paul D Quinn; Maria Harkiolaki; Peter J Sadler
Journal:  J Biol Inorg Chem       Date:  2020-03-02       Impact factor: 3.358

Review 8.  Extracellular vesicles in prostate cancer: new future clinical strategies?

Authors:  Ilaria Giusti; Vincenza Dolo
Journal:  Biomed Res Int       Date:  2014-02-23       Impact factor: 3.411

Review 9.  Plasma Membrane Lipid Domains as Platforms for Vesicle Biogenesis and Shedding?

Authors:  Hélène Pollet; Louise Conrard; Anne-Sophie Cloos; Donatienne Tyteca
Journal:  Biomolecules       Date:  2018-09-14

Review 10.  Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy?

Authors:  Stefano Martellucci; Nicola Salvatore Orefice; Adriano Angelucci; Amalia Luce; Michele Caraglia; Silvia Zappavigna
Journal:  Int J Mol Sci       Date:  2020-09-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.